---
title: "Morgan Stanley lowers Eli Lilly's target price to $1,028"
description: "Morgan Stanley has lowered Eli Lilly's target price from $1,135 to $1,028, while maintaining an \"Overweight\" rating"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/252824727.md"
published_at: "2025-08-13T09:28:52.000Z"
---

# Morgan Stanley lowers Eli Lilly's target price to $1,028

> Morgan Stanley has lowered Eli Lilly's target price from $1,135 to $1,028, while maintaining an "Overweight" rating

Morgan Stanley has lowered Eli Lilly's target price from $1,135 to $1,028, while maintaining an "Overweight" rating

### Related Stocks

- [LLY.US - Eli Lilly](https://longbridge.com/en/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Lilly's Moment: AI-Powered Pipeline Positions Shares to Surge in 2026 | Eli Lilly's stock is surging due to AI deals and a favorable drug pricing agreement. The healthcare sector, particularly | [Link](https://longbridge.com/en/news/267579204.md) |
| Eli Lilly joins a very exclusive club | Eli Lilly becomes the eleventh company to surpass $1 trillion in market capitalization, marking a milestone for healthca | [Link](https://longbridge.com/en/news/267672421.md) |
| Short Interest in Garmin Ltd. (NYSE:GRMN) Increases By 33.2% | Garmin Ltd. (NYSE:GRMN) experienced a 33.2% increase in short interest in January, totaling 3,028,012 shares as of Janua | [Link](https://longbridge.com/en/news/276018254.md) |
| Codeifai Enters AI-Backed Quantum Security Market | Codeifai Ltd :CODEIFAI ENTERS AI-BACKED QUANTUM SECURITY MARKETCOMPLETION OF ACQUISITION OF ANTENNATRANSFER.IOTOTAL CONS | [Link](https://longbridge.com/en/news/276015719.md) |
| Did Analyst Upgrades and Metal Price Tailwinds Just Shift Coeur Mining's (CDE) Investment Narrative? | Recent analyst upgrades for Coeur Mining, alongside rising gold and silver prices, have shifted focus on the company's c | [Link](https://longbridge.com/en/news/275995095.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
